Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-56518 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-56518, RRID:AB_839040
- Product name
- Mouse Monoclonal TRAIL/TNFSF10 Antibody
- Antibody type
- Monoclonal
- Description
- Protein G purified. In Jurkat, a 32 kDa band, which represents a membrane bound form of TRAIL, is observed.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 1.0 mg/ml
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Submitted references Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors.
A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells.
Leptin modulates dose-dependently the metabolic and cytolytic activities of NK-92 cells.
Tumor necrosis factor-related apoptosis-inducing ligand expression correlates to temporomandibular joint disk degeneration.
Lipid raft assembly and Lck recruitment in TRAIL costimulation mediates NF-κB activation and T cell proliferation.
Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Frontline: Induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus.
Iurlaro R, Püschel F, León-Annicchiarico CL, O'Connor H, Martin SJ, Palou-Gramón D, Lucendo E, Muñoz-Pinedo C
Molecular and cellular biology 2017 May 15;37(10)
Molecular and cellular biology 2017 May 15;37(10)
A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells.
Toriyama S, Horinaka M, Yasuda S, Taniguchi T, Aono Y, Takamura T, Morioka Y, Miki T, Ukimura O, Sakai T
Molecular cancer therapeutics 2016 Sep;15(9):2066-75
Molecular cancer therapeutics 2016 Sep;15(9):2066-75
Leptin modulates dose-dependently the metabolic and cytolytic activities of NK-92 cells.
Lamas B, Goncalves-Mendes N, Nachat-Kappes R, Rossary A, Caldefie-Chezet F, Vasson MP, Farges MC
Journal of cellular physiology 2013 Jun;228(6):1202-9
Journal of cellular physiology 2013 Jun;228(6):1202-9
Tumor necrosis factor-related apoptosis-inducing ligand expression correlates to temporomandibular joint disk degeneration.
Leonardi R, Almeida LE, Rusu M, Sicurezza E, Palazzo G, Loreto C
The Journal of craniofacial surgery 2011 Mar;22(2):504-8
The Journal of craniofacial surgery 2011 Mar;22(2):504-8
Lipid raft assembly and Lck recruitment in TRAIL costimulation mediates NF-κB activation and T cell proliferation.
Huang SC, Tsai HF, Tzeng HT, Liao HJ, Hsu PN
Journal of immunology (Baltimore, Md. : 1950) 2011 Jan 15;186(2):931-9
Journal of immunology (Baltimore, Md. : 1950) 2011 Jan 15;186(2):931-9
Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F, Liu X, Zhou Z, Yue P, Lotan R, Khuri FR, Chung LW, Sun SY
Cancer research 2005 Jul 15;65(14):6354-63
Cancer research 2005 Jul 15;65(14):6354-63
Frontline: Induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus.
Müller DB, Raftery MJ, Kather A, Giese T, Schönrich G
European journal of immunology 2004 Apr;34(4):941-51
European journal of immunology 2004 Apr;34(4):941-51
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: TRAIL/TNFSF10 Antibody (55B709.3) [NB100-56518] - Analysis of TRAIL in Jurkat lysate
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: TRAIL/TNFSF10 Antibody (55B709.3) [NB100-56518] - Analysis of TRAIL in human kidney using TRAIL antibody at 5 ug/ml.
